Abstract
This chapter outlines the latest therapeutic modalities, both surgical and non-surgical, for the treatment of localized prostate cancer. We begin by describing a modality somewhat unique to prostate cancer in conservative management (i.e., no treatment). For reasons described more fully in the main text, “watchful waiting,” may be a viable option in some men with adenocarcinoma of the prostate. We then describe radiation therapy, with the spectrum of therapeutic options ranging from external beam radiotherapy to brachytherapy to its most contemporary form in stereotactic hypofractionated radiosurgery. We go on to look at brachytherapy as yet another radiation modality in the treatment of prostate cancer. We discuss cryoablation of prostate tumors and mention high-intensity focused ultrasound in the treatment of prostatic adenocarcinoma. We finally go on to discuss surgical removal of the prostate, beginning with traditional open techniques and move on to the main body of the chapter by discussing laparoscopic radical prostatectomy, our surgical technique, and the outcomes from the latest studies that have been performed to date.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal, A., Siegel, R., Ward, E., et al.: Cancer statistics, 2007. CA Cancer J. Clin. 57(1), 43–66 (2007)
American Cancer Society: Cancer Facts and Figures 2008. American Cancer Society, Atlanta (2008)
Catalona, W.J., Smith, D.S., Ratliff, T.L., et al.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 324, 1156–1161 (1991)
Catalona, W.J., Smith, D.S., Ratliff, T.L., et al.: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270, 948–954 (1993)
Allaf, M.E., Carter, H.B.: The results of watchful waiting for prostate cancer. AUA Update Ser. 24, 1–7 (2005)
Fowler, F.J., Collins, M.M., Albertsen, P.C., et al.: Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 283, 3217–3222 (2000)
Carter, H.B., Walsh, P.C., Landis, P., et al.: Expectant management of nonpalpable prostate cancer with curative intent: preliminary results. Urology 167, 1231–1234 (2002)
Johansson, J.E.: Expectant management of early stage prostatic cancer: Swedish experience. J. Urol. 152, 1753–1756 (1994)
Klotz, L.: Active surveillance for prostate cancer: for whom? J. Clin. Oncol. 23, 8165–8169 (2005)
Choo, R., Klotz, L., Danjoux, C., et al.: Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J. Urol. 167, 1664–1669 (2002)
Lu-Yao, G.L., Yao, S.L.: Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349, 906–910 (1997)
Bill-Axelson, A., Holmberg, L., Ruutu, M., et al.: Radical prostatectomy versus watchful waiting in early prostate cancer. N. Engl. J. Med. 352, 1977–1984 (2005)
Warlick, C., Trock, B.J., Landis, P., et al.: Delayed versus immediate surgical intervention and prostate cancer outcome. J. Natl. Cancer Inst. 98, 355–357 (2006)
Epstein, J.I., Chan, D.W., Sokoll, L.J., et al.: Nonpalpabe stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings. J. Urol. 160, 2407–2411 (1998)
Pasteau, O., Degrais, P.: The radium treatment of cancer of the prostate. Arch. Roentgen Ray 18, 396 (1914)
Sklar, G.: Combined antitumor effect of suramin plus irradiation in human prostate cancer cells: The role of apoptosis. J. Urol. 150, 1526 (1993)
Zelefsky, M.J., Chan, H., Hunt, M., et al.: Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer. J. Urol. 176, 1415–1419 (2006)
Gretzer, M.B., Trock, B.J., Han, M., et al.: A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria. J. Urol. 168(pt 1), 1419–1422 (2002)
Abramowitz, M.C., Li, T., Buyyounouski, M.K., et al.: The phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer 112, 55–60 (2007)
Cox, J.D.: The American Society for Therapeutic Radiation and Oncology Consensus Panel Consensus Statement Guidelines for PSA Failure Following Radiation Therapy. Int. J. Radiat. Oncol. Biol. Phys. 37, 1035–1041 (1997)
Zietman, A.L., Chung, C.S., Coen, J.J., et al.: 10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study. J. Urol. 171, 210–214 (2004)
Dearnaley, D.P., Khoo, V.S., Norman, A.R., et al.: Comparison of radiation side effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 353, 267–272 (1999)
Morris, D.E., Emami, B., Mauch, P.M., et al.: Evidence-based review of three dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative. Int. J. Radiat. Oncol. Biol. Phys. 62, 3–19 (2005)
Pollack, A., Zagars, G.K., Starkschall, G., et al.: Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 53, 1097–1105 (2002)
Zietman, A.L., DeSilvio, M.L., Slater, J.D., et al.: Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294, 1233 (2005)
Sogani, P.C., Whitmore Jr., W.F., Hilaris, B.S., et al.: Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma. Scand. J. Urol. Nephrol. Suppl. 55, 205 (1980)
Blasko, J.C., Ragde, H., Grimm, P.D.: Transperineal ultrasound-guided implantation of the prostate: morbidity and complications. Scand. J. Urol. Nephrol. Suppl. 137, 113 (1991)
Quaranta, B.P., Marks, L.B., Anscher, M.S.: Comparing radical prostatectomy and brachytherapy for localized prostate cancer. Oncology 18, 1289–1302 (2004)
Ciezki, J.P.: Prostate brachytherapy for localized prostate cancer. Curr. Treat. Options Oncol. 6, 389–393 (2005)
Potters, L., Morgenstern Calugaru, E., et al.: 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer. J. Urol. 173, 1562–1566 (2005)
Crook, J., Fleshner, N., Roberts, C., et al.: Long-term urinary sequelae following 125Iodine prostate brachytherapy. J. Urol. 179, 141–146 (2008)
Litwin, M.S., Sadetsky, N., Pasta, D.J., et al.: Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE. J. Urol. 172, 515–519 (2004)
Vicini, F.A., Kini, V.R., Edmundson, G., et al.: A comprehensive review of prostate cancer brachytherapy: defining an optimal technique. Int. J. Radiat. Oncol. Biol. Phys. 44, 483–489 (1999)
Merrick, G.S., Butler, W.M., Wallner, K.E., et al.: Erectile function after prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 62, 437–447 (2005)
Raina, R., Agarwal, A., Goyal, K.K., et al.: Long-term potency after iodine-125 radiotherapy for prostate cancer and role of sildenafil citrate. Urology 62, 1103–1108 (2003)
Bentzen, S.M., Ritter, M.A.: The α/β ratio for prostate cancer: what is it, really? Radiother. Oncol. 76, 1–3 (2005)
King, C.R., Fowler, J.F.: A simple analytic derivation suggests that prostate cancer α/β ratio is low. Int. J. Radiat. Oncol. Biol. Phys. 51, 213–214 (2001)
King, C.R., Lehmann, J., Adler, J.R., et al.: CyberKnife radiotherapy for localized prostate cancer: rationale and technical feasibility. Tech. Cancer Res. Treat 2, 25–29 (2003)
Madsen, B.L., His, R.A., Pham, H.T., et al.: Stereotactic Hypofractionated Accurate Radiotherapy of the Prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int. J. Radiat. Oncol. Biol. Phys. 67, 1099–1105 (2007)
Gonder, M.J., Soanes, W.A., Shulman, S.: Cryosurgical treatment of the prostate. Invest. Urol. 3, 372–378 (1966)
Onik, G.M., Cohen, J.K., Reyes, G.D., et al.: Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72, 1291–1299 (1993)
Saliken, J.C., Donnelly, B.J., Rewcastle, J.C.: The evolution and state of modern technology for prostate cryosurgery. Urology 60, 26–33 (2002)
Cooper, I.S., Lee, A.S.: Cryostatic congelation: a system for producing a limited, controlled region of cooling or freezing of biological tissue. J. Nerv. Ment. Dis. 133, 259–263 (1961)
Baust, J.G., Gage, A.A.: The molecular basis of cryosurgery. BJU Int. 95, 1187–1191 (2005)
Gage, A.A., Baust, J.: Mechanisms of tissue injury in cryosurgery. Cryobiology 37, 171–186 (1998)
Hoffmann, N.E., Bischof, J.C.: The cryobiology of cryosurgical injury. Urology 60, 40–49 (2002)
Bahn, D.K., Lee, F., Badalament, R., et al.: Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 60, 3–11 (2002)
Donnelly, B.J., Saliken, J.C., Ernst, D.S., et al.: Prospective trial of cryosurgical ablation of the prostate: five year results. Urology 60, 645–649 (2002)
Ellis, D.S.: Cryosurgery as a primary treatment for localized prostate cancer: a community hospital experience. Urology 60, 34–39 (2002)
Han, K.-R., Cohen, J.K., Miller, R.J., et al.: Treatment of organ-confined prostate cancer with third generation cryosurgery: preliminary multi-center experience. J. Urol. 170, 1126–1130 (2003)
Shinohara, K.: Prostate cancer cryotherapy. Urol. Clin. North Am. 30, 725–736 (2003)
Robinson, J.W., Donnelly, B.J., Saliken, J.C., et al.: Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 60(2 suppl 1), 12–18 (2002)
Katz, A.E., Rewcastle, J.C.: The current and potential role of cryoablation as a primary therapy for localized prostate cancer. Curr. Oncol. Rep. 5, 231–238 (2003)
Long, J.P., Bahn, D., Lee, F., et al.: Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 57(3), 518–523 (2001)
Madersbacher, S., Padevilla, M., Vingers, L., et al.: Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res. 55, 3346–3351 (1995)
Chapelon, J.Y., Ribault, M., Vernier, F., et al.: Treatment of localized prostate cancer with transrectal high intensity focused ultrasound. Eur. J. Ultrasound 9, 31–38 (1999)
Thuroff, S., Chaussy, C., Vallancien, G., et al.: High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J. Endourol. 17, 673–677 (2003)
Beerlage, H.P., Thuroff, S., Debruyne, F.M., et al.: Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54, 273–277 (1999)
Blana, A., Walter, B., Rogenhofer, S., et al.: High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63, 297–300 (2004)
Uchida, T., Nitta, M., Hongo, S., et al.: High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer. Urology 70(3 Supp 1), 2 (2007)
Gelet, A., Chapelon, J.Y., Bouvier, R., et al.: Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur. Urol. 40, 124–129 (2001)
Vallancien, G., Prapotnich, D., Cathelineau, X., et al.: Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. Urology 171, 2265–2267 (2004)
Young, H.H.: The early diagnosis and radical cure of carcinoma of the prostate. Johns Hopkins Hosp. Bull. 16, 315–321 (1905)
Millin, T.: Retropubic prostatectomy: a new extra vesical technique. Lancet 2, 693–696 (1945)
Walsh, P.C., Donker, P.J.: Impotence following radical prostatectomy: insight into etiology and prevention. J. Urol. 128, 492–497 (1982)
Walsh, P.C.: The discovery of the cavernous nerves and development of nerve-sparing radical prostatectomy. J. Urol. 177, 1632–1635 (2007)
Kundu, S.D., Roehl, K.A., Eggener, S.E., et al.: Potency, continence and complications in 3, 477 consecutive radical retropubic prostatectomies. J. Urol. 172, 2227–2231 (2004)
Teichman, J.M., Reddy, P.K., Hulbert, J.C.: Laparoscopic pelvic lymph node dissection, laparoscopically assisted seminal vesicle mobilization, and total perineal prostatectomy versus radical retropubic prostatectomy for prostate cancer. Urology 45, 823 (1995)
Meng, M.V., Carroll, P.R.: When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis. J. Urol. 164, 1235 (2000)
Janoff, D.M., Parra, R.O.: Contemporary appraisal of radical perineal prostatectomy. J. Urol. 173, 1863–1870 (2005)
Schuessler, W.W., Kavoussi, L.R., Clayman, R.V.: Laparoscopic radical prostatectomy: initial case report [abstr 130]. J. Urol. Suppl. 147, 246A (1992)
Schuessler, W.W., Schulam, P.G., Clayman, R.V., et al.: Laparoscopic radical prostatectomy: initial short-term experience. Urology 50, 854–857 (1997)
Abbou, C.C., Salomon, L., Hoznek, A., et al.: Laparoscopic radical prostatectomy: preliminary results. Urology 55, 630–634 (2000)
Guillonneau, B., Cathelineau, X., Baret, E., et al.: Laparoscopic radical prostatectomy: technical and early oncological assessment of 40 operations. Eur. Urol. 36, 14 (1999)
Rassweiler, J., Sentker, L., Seeman, O., et al.: Heilbronn laparoscopic radical prostatectomy: technique and results after 100 cases. Eur. Urol. 40, 54 (2001)
Bollens, R., Vanden, B.M., Rhoumeguere, T.H., et al.: Extraperitoneal laparoscopic radical prostatectomy: results after 50 cases. Eur. Urol. 40, 65 (2001)
Trabulsi, E.J., Guillonneau, B.: Laparoscopic radical prostatectomy. J. Urol. 173, 1072–1079 (2005)
Shah, O., Robbins, D.A., Melamed, J., et al.: The New York University nerve sparing algorithm decreases the rate of positive surgical margins following radical retropubic prostatectomy. J. Urol. 169, 2147–2152 (2003)
Hsia, M., Ponsky, L., Rosenblatt, S., et al.: Laparoscopic inguinal hernia repair complicates future pelvic oncologic surgery. Ann. Surg. 240, 922 (2004)
Stolzenburg, J.U., Anderson, C., Rabenalt, R., et al.: Endoscopic extraperitoneal radical prostatectomy in patients with prostate cancer and previous laparoscopic inguinal mesh placement for hernia repair. World J. Urol. 23, 295–299 (2005)
Menon, M., Shrivastava, A., Tewari, A., et al.: Laparoscopic and robot assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J. Urol. 168, 945–949 (2002)
Aherling, T.E., Skarecky, D., Lee, D., et al.: Successful transfer of open surgical skills to a laparoscopic environment using a robotic interface: initial experience with laparoscopic radical prostatectomy. J. Urol. 170, 1738 (2003)
Guillonneau, B.: What robotics in urology?A current point of view. Eur. Urol. 43, 103 (2003)
Tooher, R., Swindle, P., Woo, H., et al.: Laparoscopic radical prostatectomy for localized prostate cancer: a systematic review of comparative studies. J. Urol. 175, 2011–2017 (2006)
Hoznek, A., Salomon, L., Olsson, L.E., et al.: Laparoscopic radical prostatectomy The Creteil experience. Eur. Urol. 40, 38 (2001)
Turk, I., Deger, S., Winkelmann, B., et al.: Laparoscopic radical prostatectomy. Technical aspects and experience with 125 cases. Eur. Urol. 40, 46 (2001)
Eden, C.G., Cahill, D., Vass, J.A., et al.: Laparoscopic radical prostatectomy: the initial UK series. BJU Int. 90, 876 (2002)
Guillonneau, B., Rozet, F., Cathelineau, X., et al.: Perioperative complications of laparoscopic radical prostatectomy: the Montsouris 3-year experience. J. Urol. 167, 51–56 (2002)
Rassweiler, J., Seemann, O., Schulze, M., et al.: Laparoscopic versus open radical prostatectomy a comparative study at a single institution. J. Urol. 169, 1689 (2003)
Dillioglugil, O., Leibman, N.S., Kattan, M.W., et al.: Risk factors for complications and morbidity after radical retropubic prostatectomy. J. Urol. 157(5), 1760–1767 (1997)
Lepor, H., Neder, A.M., Ferrandino, M.N.: Intraoperative and postoperative complications of radical retropubic prostatectomy in a consecutive series of 1, 000 cases. J. Urol. 166(5), 1729–1733 (2001)
Augustin, H., Pummer, K., Daghofer, F., et al.: Patient self-reporting questionnaire on urological morbidity and bother after radical prostatectomy. Eur. Urol. 42, 112–117 (2002)
Guillonneau, B., Cathelineau, X., Doublet, J.D., et al.: Laparoscopic radical prostatectomy: assessment after 550 procedures. Crit. Rev. Oncol. Hematol. 43, 123 (2002)
Walsh, P.C., Marschke, P., Ricker, D., et al.: Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55, 58–61 (2000)
Han, M., Partin, A.W., Pound, C.R., et al.: Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol. Clin. North Am. 28, 555–565 (2001)
Roehl, K.A., Han, M., Ramos, C.G., et al.: Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3, 478 consecutive patients: long-term results. J. Urol. 172, 910–914 (2004)
Bianco Jr., F.J., Scardino, P.T., Eastham, J.A.: Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 66, 83–94 (2005)
Bhayani, S.B., Pavlovich, C.P., Hsu, T.S., et al.: Prospective comparison of short-term convalescence laparoscopic radical prostatectomy versus open radical retropubic prostatectomy. Urology 61, 612 (2003)
Bickert, D., Frickel, D.: Laparoscopic radical prostatectomy. AORN J. 75, 762 (2002)
Brown, J.A., Garlitz, C., Gomella, L.G., et al.: Perioperative morbidity of laparoscopic radical prostatectomy compared with open radical retropubic prostatectomy. Urol. Oncol. 22, 102 (2004)
Egawa, S., Kuruma, H., Suyama, K., et al.: Delayed recovery of urinary continence after laparoscopic radical prostatectomy. Int. J. Urol. 10, 207 (2003)
Martorana, G., Manferrari, F., Bertaccini, A., et al.: Laparoscopic radical prostatectomy oncological evaluation in the early phase of the learning curve comparing to retropubic approach. Arch. Ital. Urol. Androl. 76, 1 (2004)
Salomon, L., Anastasiadis, A.G., Levrel, O., et al.: Location of positive surgical margins after retropubic, perineal, and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology 61, 386 (2003)
Hara, I., Kawabata, G., Miyake, H., et al.: Comparison of quality of life following laparoscopic and open prostatectomy for prostate cancer. J. Urol. 169, 2045 (2003)
Pound, C.R., Partin, A.W., Epstein, J.I., et al.: Prostate-specific antigen after anatomic radical retropubic prostatectomy Patterns of recurrence and cancer control. Urol. Clin. North Am. 24, 395 (1997)
Pavlovich, C.P., Trock, B.J., Sulman, A., et al.: 3-year actuarial biochemical recurrence-free survival following laparoscopic radical prostatectomy: experience from a tertiary referral center in the united states. J. Urol. 179, 917–922 (2008)
Jacobsen, N.-E.B., Moore, K.N., Estey, E., et al.: Open versus laparoscopic radical prostatectomy: a prospective comparison of postoperative urinary incontinence rates. J. Urol. 177, 615–619 (2007)
Anastasiadis, A.G., Salomon, L., Katz, R., et al.: Radical retropubic versus laparoscopic prostatectomy: a prospective comparison of functional outcome. Urology 62, 292 (2003)
Litwin, M.S., Melmed, G.Y., Nakazon, T.: Life after radical prostatectomy: a longitudinal study. J. Urol. 166, 587 (2001)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Vricella, G.J., Ponsky, L.E. (2011). Cancer of the Prostate. In: Matteotti, R., Ashley, S. (eds) Minimally Invasive Surgical Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-45021-4_32
Download citation
DOI: https://doi.org/10.1007/978-3-540-45021-4_32
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-45018-4
Online ISBN: 978-3-540-45021-4
eBook Packages: MedicineMedicine (R0)